Literature DB >> 18379052

Proteomic analysis of apoptosis induced by xanthoangelol, a major constituent of Angelica keiskei, in neuroblastoma.

Kou Motani1, Keiichi Tabata, Yumiko Kimura, Soichiro Okano, Yasuko Shibata, Yoshimitsu Abiko, Hisashi Nagai, Toshihiro Akihisa, Takashi Suzuki.   

Abstract

Neuroblastoma is the most common solid tumor in children. Despite aggressive chemotherapy, the prognosis of patients with advanced neuroblastoma is still very poor. Our recent study showed that xanthoangelol, a major chalcone constituent of the stem exudates of Angelica keiskei, induced caspase-3-dependent apoptosis in neuroblastoma cells. However, details of the mechanism underlying its apoptotic action are still unclear. Here we show that xanthoangelol triggers oxidative stress by generation of reactive oxygen species and induces apoptosis through release of cytochrome c and activation of caspase-9 in IMR-32 cells. Pretreatment with an antioxidant, vitamin E, prevented the increase of reactive oxygen species and apoptosis induced by xanthoangelol. Proteomic analysis using 2-dimensional electrophoresis and MALDI-TOF-MS revealed that DJ-1 protein was involved in xanthoangelol-induced apoptosis. DJ-1 responded to its oxidative stress status by being oxidized itself. Furthermore, DJ-1 was down-regulated by xanthoangelol, leading to loss of antioxidant function and acceleration of apoptosis. We also show that xanthoangelol has a cytotoxic effect on drug-resistant LA-N-1 and NB-39 cells as well as drug-sensitive IMR-32 and SK-N-SH cells. These findings suggest that xanthoangelol induces apoptosis by increasing reactive oxygen species and targeting DJ-1, and such mechanism may be an effective therapeutic approach for advanced neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18379052     DOI: 10.1248/bpb.31.618

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  New 4-maleamic acid and 4-maleamide peptidyl chalcones as potential multitarget drugs for human prostate cancer.

Authors:  Juan Rodrigues; Claudia Abramjuk; Luis Vásquez; Neira Gamboa; José Domínguez; Bianca Nitzsche; Michael Höpfner; Radostina Georgieva; Hans Bäumler; Carsten Stephan; Klaus Jung; Michael Lein; Anja Rabien
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

Review 2.  The role of chalcones in suppression of NF-κB-mediated inflammation and cancer.

Authors:  Vivek R Yadav; Sahdeo Prasad; Bokyung Sung; Bharat B Aggarwal
Journal:  Int Immunopharmacol       Date:  2010-12-22       Impact factor: 4.932

3.  Dietary chalcones with chemopreventive and chemotherapeutic potential.

Authors:  Barbora Orlikova; Deniz Tasdemir; Frantisek Golais; Mario Dicato; Marc Diederich
Journal:  Genes Nutr       Date:  2011-02-04       Impact factor: 5.523

4.  Application of proteomics to soft tissue sarcomas.

Authors:  Tadashi Kondo; Daisuke Kubota; Akira Kawai
Journal:  Int J Proteomics       Date:  2012-06-19

5.  Bioavailability of plant pigment phytochemicals in Angelica keiskei in older adults: A pilot absorption kinetic study.

Authors:  Camila R Correa; C-Y Oliver Chen; Giancarlo Aldini; Helen Rasmussen; Carlos F Ronchi; Carolina Berchieri-Ronchi; Soo-Muk Cho; Jeffrey B Blumberg; Kyung-Jin Yeum
Journal:  Nutr Res Pract       Date:  2014-09-15       Impact factor: 1.926

Review 6.  Novel Insights into PARK7 (DJ-1), a Potential Anti-Cancer Therapeutic Target, and Implications for Cancer Progression.

Authors:  Wook Jin
Journal:  J Clin Med       Date:  2020-04-26       Impact factor: 4.241

7.  Endoplasmic reticulum stress triggers Xanthoangelol-induced protective autophagy via activation of JNK/c-Jun Axis in hepatocellular carcinoma.

Authors:  Zichao Li; Luying Zhang; Mingquan Gao; Mei Han; Kaili Liu; Zhuang Zhang; Zhi Gong; Lifei Xing; Xianzhou Shi; Kui Lu; Hui Gao
Journal:  J Exp Clin Cancer Res       Date:  2019-01-08

8.  An update on antitumor activity of naturally occurring chalcones.

Authors:  En-Hui Zhang; Ru-Feng Wang; Shu-Zhen Guo; Bin Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-17       Impact factor: 2.629

Review 9.  Angelica keiskei, an emerging medicinal herb with various bioactive constituents and biological activities.

Authors:  Yun-Seo Kil; Sally T Pham; Eun Kyoung Seo; Mahtab Jafari
Journal:  Arch Pharm Res       Date:  2017-04-24       Impact factor: 4.946

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.